Longitudinal assessment of oxaliplatin-induced neuropathy.
Susanna B
SB
Park
Martin
M
Koltzenburg
Cindy S -Y
CS
Lin
Matthew C
MC
Kiernan
D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D011115:Polyneuropathies / Q000139:chemically induced* / Q000503:physiopathology*
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds